ATE29026T1 - Sulfonylharnstoff-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen die sie enthalten. - Google Patents
Sulfonylharnstoff-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen die sie enthalten.Info
- Publication number
- ATE29026T1 ATE29026T1 AT83401824T AT83401824T ATE29026T1 AT E29026 T1 ATE29026 T1 AT E29026T1 AT 83401824 T AT83401824 T AT 83401824T AT 83401824 T AT83401824 T AT 83401824T AT E29026 T1 ATE29026 T1 AT E29026T1
- Authority
- AT
- Austria
- Prior art keywords
- manufacture
- pharmaceutical compositions
- compositions containing
- formula
- image
- Prior art date
Links
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Laminated Bodies (AREA)
- Investigating Strength Of Materials By Application Of Mechanical Stress (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8216012A FR2533563A1 (fr) | 1982-09-23 | 1982-09-23 | Nouveaux derives de la sulfonyluree, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
| EP83401824A EP0109866B1 (de) | 1982-09-23 | 1983-09-20 | Sulfonylharnstoff-Derivate, Verfahren zur Herstellung und pharmazeutische Zusammenstellungen die sie enthalten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE29026T1 true ATE29026T1 (de) | 1987-09-15 |
Family
ID=9277666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT83401824T ATE29026T1 (de) | 1982-09-23 | 1983-09-20 | Sulfonylharnstoff-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen die sie enthalten. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4505921A (de) |
| EP (1) | EP0109866B1 (de) |
| JP (1) | JPS5980660A (de) |
| AT (1) | ATE29026T1 (de) |
| AU (1) | AU557000B2 (de) |
| CA (1) | CA1213892A (de) |
| DE (1) | DE3373094D1 (de) |
| DK (1) | DK433583A (de) |
| ES (1) | ES8501373A1 (de) |
| FR (1) | FR2533563A1 (de) |
| IE (1) | IE56004B1 (de) |
| NZ (1) | NZ205700A (de) |
| OA (1) | OA07536A (de) |
| PT (1) | PT77374B (de) |
| ZA (1) | ZA837055B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8609331D0 (en) * | 1986-04-16 | 1986-05-21 | Pfizer Ltd | Anti-arrythmia agents |
| DE3800577A1 (de) * | 1988-01-12 | 1989-07-20 | Basf Ag | 3-(4-amino-2-hydroxyphenyl)-1-oxo-isoindolenine, verfahren zu deren herstellung und deren verseifung zu 2-(4-amino-2-hydroxybenzoyl)-benzoesaeuren |
| US5217970A (en) * | 1989-06-26 | 1993-06-08 | Sankyo Company, Limited | Use of isoxazolin-3-one derivatives as antidepressants |
| US5262413A (en) * | 1989-06-26 | 1993-11-16 | Sankyo Company, Limited | Use of isoxazolin-3-one derivatives as antidepressants |
| JPH04217684A (ja) * | 1990-05-30 | 1992-08-07 | Shionogi & Co Ltd | アルド−ス還元酵素阻害物質 |
| GB0419481D0 (en) * | 2004-09-02 | 2004-10-06 | Cancer Rec Tech Ltd | Isoindolin-1-one derivatives |
| GB0811643D0 (en) | 2008-06-25 | 2008-07-30 | Cancer Rec Tech Ltd | New therapeutic agents |
| AU2011257964B2 (en) * | 2010-05-24 | 2014-10-30 | Ozstar Therapeutics Pty Ltd | Anti-diabetic compositions and methods |
| CN103880826B (zh) * | 2013-12-10 | 2016-08-17 | 中山大学 | 一种异苯并呋喃酮化合物及其制备方法和应用 |
| GB201517217D0 (en) | 2015-09-29 | 2015-11-11 | Astex Therapeutics Ltd And Cancer Res Technology Ltd | Pharmaceutical compounds |
| GB201517216D0 (en) | 2015-09-29 | 2015-11-11 | Cancer Res Technology Ltd And Astex Therapeutics Ltd | Pharmaceutical compounds |
| GB201704966D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| GB201704965D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU47776A1 (de) * | 1964-07-30 | 1966-07-13 | ||
| DE1445774A1 (de) * | 1964-07-30 | 1969-01-23 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
| US3879418A (en) * | 1970-09-22 | 1975-04-22 | Sandoz Ag | 1,1-Disubstituted-2-alkyl 3-oxo-isoindolines |
| DE2253251A1 (de) * | 1972-10-30 | 1974-05-09 | Thomae Gmbh Dr K | Neue phthalimido-sulfonylharnstoffe |
-
1982
- 1982-09-23 FR FR8216012A patent/FR2533563A1/fr active Granted
-
1983
- 1983-09-06 US US06/529,735 patent/US4505921A/en not_active Expired - Fee Related
- 1983-09-20 EP EP83401824A patent/EP0109866B1/de not_active Expired
- 1983-09-20 AT AT83401824T patent/ATE29026T1/de not_active IP Right Cessation
- 1983-09-20 DE DE8383401824T patent/DE3373094D1/de not_active Expired
- 1983-09-21 AU AU19351/83A patent/AU557000B2/en not_active Ceased
- 1983-09-22 IE IE2222/83A patent/IE56004B1/xx unknown
- 1983-09-22 PT PT77374A patent/PT77374B/pt not_active IP Right Cessation
- 1983-09-22 JP JP58176173A patent/JPS5980660A/ja active Pending
- 1983-09-22 CA CA000437340A patent/CA1213892A/fr not_active Expired
- 1983-09-22 OA OA58105A patent/OA07536A/xx unknown
- 1983-09-22 NZ NZ205700A patent/NZ205700A/en unknown
- 1983-09-22 ZA ZA837055A patent/ZA837055B/xx unknown
- 1983-09-22 DK DK433583A patent/DK433583A/da not_active Application Discontinuation
- 1983-09-23 ES ES525920A patent/ES8501373A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IE56004B1 (en) | 1991-03-13 |
| FR2533563B1 (de) | 1985-05-24 |
| ES525920A0 (es) | 1984-11-16 |
| ZA837055B (en) | 1984-04-25 |
| DK433583D0 (da) | 1983-09-22 |
| FR2533563A1 (fr) | 1984-03-30 |
| NZ205700A (en) | 1986-06-11 |
| PT77374A (fr) | 1983-10-01 |
| US4505921A (en) | 1985-03-19 |
| AU1935183A (en) | 1984-03-29 |
| ES8501373A1 (es) | 1984-11-16 |
| OA07536A (fr) | 1985-03-31 |
| IE832222L (en) | 1984-03-23 |
| DE3373094D1 (en) | 1987-09-24 |
| JPS5980660A (ja) | 1984-05-10 |
| EP0109866A1 (de) | 1984-05-30 |
| CA1213892A (fr) | 1986-11-12 |
| EP0109866B1 (de) | 1987-08-19 |
| PT77374B (fr) | 1986-02-18 |
| AU557000B2 (en) | 1986-11-27 |
| DK433583A (da) | 1984-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU90192I2 (fr) | Desirudine et ses sels et dérivés pharmaceutiquement acceptables (revasc) | |
| ATE1288T1 (de) | Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel. | |
| PT77898B (en) | Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation | |
| SE7506386L (sv) | Alkanolaminderivat och sett for deras framstellning | |
| ATE2271T1 (de) | 4-(substituierte thiazolyl)-3-hydroxy-3-pyrrolin2,5-dion-verbindungen, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung. | |
| ATE7697T1 (de) | Substituierte pyrazinyl-1,2,4-oxadiazol-5-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| ATE29026T1 (de) | Sulfonylharnstoff-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen die sie enthalten. | |
| ATE17728T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE7699T1 (de) | Cephalosporinderivate, sie enthaltende pharmazeutische praeparate und verfahren zu ihrer herstellung. | |
| ATE38988T1 (de) | Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| ATE9350T1 (de) | Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung. | |
| UA48958C2 (uk) | 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі | |
| DE3361990D1 (en) | Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments | |
| DE68917937D1 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung. | |
| PT83309A (de) | Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel | |
| ATE3552T1 (de) | Verfahren zur herstellung von phosphono-hydroxy- essigsaeure und salzen derselben sowie diese enthaltende autivirale mittel. | |
| DE69103624D1 (de) | Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung. | |
| ATE27157T1 (de) | Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| IL82925A0 (en) | Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them | |
| ATE22282T1 (de) | Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE37370T1 (de) | Triazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ATE69809T1 (de) | Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten. | |
| ATE7911T1 (de) | Pharmazeutisch zulassbare salze von 4'-(9acridinylamino)methansulfon-m-anisid, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE2429T1 (de) | 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| FI820172L (fi) | Basiskt substituerade antranilsyror deras framstaellningsfoerfarande och anvaendning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |